(Q85044094)
Statements
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial (English)
K-H Liesenfeld
T Lehr
C Dansirikul
P A Reilly
S J Connolly
M D Ezekowitz
S Yusuf
S Haertter
1 November 2011